Insights
SaMD AI/ML
AI/ML-based Software as a Medical Device cybersecurity and regulatory compliance consulting.
Artificial Intelligence and Machine Learning (AI/ML)-based Software as a Medical Device (SaMD) represents one of the most rapidly evolving areas in healthcare technology. The FDA has issued guidance on AI/ML-based SaMD, and CyberActa helps organizations navigate these requirements.
Our services for AI/ML SaMD include pre-submission meeting preparation, algorithm change protocols, predetermined change control plans, and post-market performance monitoring strategies aligned with FDA's action plan for AI/ML-based SaMD.
We work with your development and regulatory teams to ensure that your AI/ML-based SaMD meets both cybersecurity and regulatory requirements throughout its lifecycle.